The global market for Iloprost Drugs was valued at US$ 87.2 million in the year 2024 and is projected to reach a revised size of US$ 78 million by 2031, growing at a CAGR of -1.6% during the forecast period.
Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud"s phenomenon and other diseases in which the blood vessels are constricted and blood can"t flow to...
The global market for Flower Essences was valued at US$ 47.1 million in the year 2024 and is projected to reach a revised size of US$ 70.5 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Flower essences are liquid extracts used to address profound issues of emotional well-being, soul development, and mind-body health.They can address imbalances on an emotional, mental, physi...
The global market for Sarcopenia Treatments was valued at US$ 3021 million in the year 2024 and is projected to reach a revised size of US$ 4120 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
China is the largest consumption region of Sarcopenia Treatment, with market share n...
The global market for Activin-A was valued at US$ 17.7 million in the year 2024 and is projected to reach a revised size of US$ 39.9 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Activins, members of the TGF-beta superfamily, are disulfide-linked dimeric proteins originally purified from gonadal fluids as proteins that stimulated pituitary follicle stimulating hormone (FS...
The global market for Oligonucleotide Therapeutics was valued at US$ 7536 million in the year 2024 and is projected to reach a revised size of US$ 9690 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Oligonucleotide therapeutics are a class of precision medicines composed of short DNA or RNA sequences designed to specifically target and modulate the expression of genes invol...
The global market for Diabetic Foot Ulcer (DFU) Treatment was valued at US$ 5577 million in the year 2024 and is projected to reach a revised size of US$ 8503 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Diabetic foot ulcers are among one of the major g...
The global market for Recombinant Proteins was valued at US$ 1244 million in the year 2024 and is projected to reach a revised size of US$ 2896 million by 2031, growing at a CAGR of 13.0% during the forecast period.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene....
The global market for Breviscapine for Injection was valued at US$ 459 million in the year 2024 and is projected to reach a revised size of US$ 551 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Breviscapine for injection is a sterile injection made from the traditional Chinese medicine Breviscapine, which is extracted by modern technology to extract the active ingredients...
The global market for Linagliptin DPP-4 Inhibitors was valued at US$ 473 million in the year 2024 and is projected to reach a revised size of US$ 738 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Linagliptin is an oral antidiabetic drug that belongs to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is used to lower blood sugar levels in adults with Type 2 Diabe...
The global market for Anti-HIV-1 Drugs was valued at US$ 30210 million in the year 2024 and is projected to reach a revised size of US$ 46370 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Anti-HIV-1 drugs are antiviral medications designed to inhibit the replication of Human Immunodeficiency Virus Type 1 (HIV-1), the predominant strain of HIV responsible for Acquired Immun...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals